To overcome these obstacles, cancer cells develop effective lipid metabolism machinery, including an increase in the activity of key lipogenic enzymes, such as adenosine triphosphate (ATP)-citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), and stearoyl-CoA desaturase (SCD) [6]. The gene discussed is FAS; the disease is cancer.